Neuroleptic-opioid interaction: relevance to tardive dyskinesia.
D000818:Animals; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000378:metabolism* / Q000627:therapeutic use; D001921:Brain / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D004409:Dyskinesia, Drug-Induced / Q000503:physiopathology*; D006801:Humans; D011957:Receptors, Opioid / Q000187:drug effects* / Q000378:metabolism
D014150:Antipsychotic Agents; D011957:Receptors, Opioid; D004298:Dopamine